Terms: = Ovarian cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Clinical Outcome
4 results:
1. BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
Lesnock JL; Darcy KM; Tian C; Deloia JA; Thrall MM; Zahn C; Armstrong DK; Birrer MJ; Krivak TC
Br J Cancer; 2013 Apr; 108(6):1231-7. PubMed ID: 23462720
[TBL] [Abstract] [Full Text] [Related]
2. Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.
Gao Y; Liu Z; Chen X; Luo W; Zhang L; Wang J
BMC Cancer; 2011 Oct; 11():439. PubMed ID: 21989202
[TBL] [Abstract] [Full Text] [Related]
3. Counterpoint: Intraperitoneal chemotherapy: an investigational treatment in ovarian cancer.
Ozols RF
J Natl Compr Canc Netw; 2004 Nov; 2(6):555-60. PubMed ID: 19780299
[TBL] [Abstract] [Full Text] [Related]
4. High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.
Bonetti A; Howell SB; McClay E; Kirmani S; Goel R; Plaxe S; Braly P; Kim S
Gynecol Oncol; 1993 Jun; 49(3):318-24. PubMed ID: 8314533
[TBL] [Abstract] [Full Text] [Related]
